Plasma Blood Resuscitation Protects Blood Vessel Walls
5/31/2011
Using plasma rather than standard resuscitation fluids seems to improve survival in trauma patients with massive blood loss...
Bowel cancer, already Australia's second leading cause of cancer death, is following international trends and becoming more common in younger people, especially those under 35 years...
Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that results from an economic analysis carried out by the UK NHS National Innovation Centre identified the Celution® System for breast reconstruction as an innovative technology that is bringing benefits to National Health Service (NHS) hospitals and breast cancer patients...
Hope For Ovarian Cancer Patients With The Help Of Targeted Testing
5/31/2011
Women with ovarian cancer could be helped by a new test that identifies the specific type of tumour they have, a conference will hear this week. Researchers at the University of Edinburgh hope this improved diagnosis will help doctors to personalise treatment programmes so that patients receive the most effective drugs...
2nd Annual Clinical Trials For Oncology - Boston Marriott Copley, 26th - 28th September 2011
5/31/2011
Clinical Trials for Oncology focuses on the need of drug developers to bring their clinical trials in line with developments in personalized medicine, targeted therapeutics and adaptive trial design. The agenda will show how the most innovative scientific concepts are actively being put into practice within the industry, enabling you to: 1...
Affymax, Inc. (NASDAQ:AFFY) and Takeda Pharmaceutical Company Limited (TSE: 4502, "Takeda") today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the investigational agent peginesatide (formerly known as Hematide™) for the treatment of anemia associated with chronic renal failure (CRF) in adult patients on dialysis...
With A Hot Summer In Prospect, MDU Warns GPs To Be Vigilant For Malignant Melanomas, UK
5/31/2011
With spring 2011 set to be one of the driest on record and warnings that the UK will have a heat-wave summer, the Medical Defence Union (MDU) has issued advice to GPs to help avoid the pitfalls of treating skin lesions, after revealing that it has been notified of 134 cases involving patients with malignant melanoma in the last five years...
Affymetrix Selects BioDiscovery As OncoScan™ FFPE Express Preferred Software Provider
5/31/2011
Affymetrix, Inc. (NASDAQ:AFFX) today announced a co-marketing agreement naming BioDiscovery, Inc. its preferred software provider for Affymetrix OncoScan™ FFPE Express Service data analysis...
Millennium: The Takeda Oncology Company and Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that an oral presentation and a poster presentation featuring brentuximab vedotin (SGN-35) will be presented at the 16th Congress of the European Hematology Association (EHA) being held from June 9-12, 2011, in London...
Human Health At Risk From 'E-Waste Pollution'
5/31/2011
In addition to its damaging effect on the environment and its illegal smuggling into developing countries, researchers have now linked e-waste to adverse effects on human health, such as inflammation and oxidative stress - precursors to cardiovascular disease, DNA damage and possibly cancer...